The three clinical subtypes of BC include hormone receptor positive (HR+), human epidermal growth factor receptor 2 positive (HER2+), and triple negative breast cancer (TNBC), which does not strongly express estrogen receptors, progesterone receptors, or HER2. This evidence concerns the gene ERBB2 and breast cancer.